Clinical Trials Directory

Trials / Completed

CompletedNCT02981030

Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western Ukraine

Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western Ukraine: A Demonstration Study of 800 mcg Buccal Misoprostol Following 200 mg Mifepristone for Abortion up to 70 Days Gestation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Gynuity Health Projects · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The study will examine how a simplified outpatient medical abortion procedure using mifepristone and misoprostol, with the option to take mifepristone at a place of woman's choosing, works in Ukraine. The investigators intend to demonstrate the efficacy of oral administration of 200 mg mifepristone and buccal administration of 800 mcg misoprostol with gestations through 70 days, as well as the acceptability of this method.

Conditions

Interventions

TypeNameDescription
DRUGMifepristoneWomen seeking medical abortion will be offered the option to take mifepristone at home
DRUGMisoprostolWomen seeking medical abortion will be offered the option to take misoprostol at home. Misoprostol will be administered buccally.

Timeline

Start date
2016-11-23
Primary completion
2017-06-30
Completion
2017-06-30
First posted
2016-12-02
Last updated
2018-06-18

Locations

2 sites across 1 country: Ukraine

Source: ClinicalTrials.gov record NCT02981030. Inclusion in this directory is not an endorsement.